Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-02-28 Sale | 2022-03-01 5:01 pm | Aprea Therapeutics Inc. | APRE | Attar Eyal C. SVP, Chief Medical Officer | 36,000 | $1.73 | $62,280 | 47,331 (Indirect Direct) | View |
| 2021-09-16 Sale | 2021-09-20 5:29 pm | Aprea Therapeutics Inc. | APRE | Attar Eyal C. SVP, Chief Medical Officer | 15,968 | $4.68 | $74,730 | 83,331 (Indirect Direct) | View |
| 2019-10-07 Purchase | 2019-10-07 7:18 pm | Aprea Therapeutics Inc. | APRE | Attar Eyal C. SVP, Chief Medical Officer | 400 | $15 | $6,000 | 77,830 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-06 Tax Withholding | 2024-02-08 5:10 pm | N/A N/A | Vor Biopharma Inc. | VOR | Attar Eyal C. CHIEF MEDICAL OFFICER | 1,180 | $2.32 | 112,853 (Direct) | View |
| 2024-01-29 Option Award | 2024-01-31 7:38 pm | N/A 2034-01-28 | Vor Biopharma Inc. | VOR | Attar Eyal C. CHIEF MEDICAL OFFICER | 187,500 | $0 | 239,033 (Direct) | View |
| 2023-11-06 Tax Withholding | 2023-11-08 4:10 pm | N/A N/A | Vor Biopharma Inc. | VOR | Attar Eyal C. Chief Medical Officer | 999 | $1.82 | 51,533 (Direct) | View |
| 2023-08-07 Tax Withholding | 2023-08-09 4:31 pm | N/A N/A | Vor Biopharma Inc. | VOR | Attar Eyal C. Chief Medical Officer | 999 | $2.67 | 52,532 (Direct) | View |
| 2023-05-08 Tax Withholding | 2023-05-10 4:14 pm | N/A N/A | Vor Biopharma Inc. | VOR | Attar Eyal C. Chief Medical Officer | 969 | $4.14 | 53,531 (Direct) | View |
| 2023-02-06 Option Award | 2023-02-08 4:23 pm | N/A 2033-02-05 | Vor Biopharma Inc. | VOR | Attar Eyal C. Chief Medical Officer | 163,500 | $0 | 163,500 (Direct) | View |
| 2022-10-11 Option Award | 2022-10-12 4:24 pm | N/A 2032-10-10 | Vor Biopharma Inc. | VOR | Attar Eyal C. Chief Medical Officer | 364,000 | $0 | 364,000 (Direct) | View |
| 2022-06-03 Tax Withholding | 2022-06-07 5:00 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Attar Eyal C. SVP, Chief Medical Officer | 32,667 | $0.805 | 57,564 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 5:01 pm | N/A 2032-03-10 | Aprea Therapeutics Inc. | APRE | Attar Eyal C. SVP, Chief Medical Officer | 228,800 | $0 | 276,131 (Direct) | View |
| 2021-08-25 Tax Withholding | 2021-08-27 5:00 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | Attar Eyal C. SVP, Chief Medical Officer | 9,032 | $3.98 | 99,299 (Direct) | View |
| 2021-02-25 Option Award | 2021-03-01 7:12 pm | N/A 2031-02-25 | Aprea Therapeutics Inc. | APRE | Attar Eyal C. SVP, Chief Medical Officer | 251,000 | $0 | 251,400 (Direct) | View |
| 2020-03-24 Option Award | 2020-03-26 5:01 pm | N/A 2030-03-24 | Aprea Therapeutics Inc. | APRE | Attar Eyal C. SVP, Chief Medical Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2019-10-07 Option Award | 2019-10-07 7:18 pm | N/A 2029-10-02 | Aprea Therapeutics Inc. | APRE | Attar Eyal C. SVP, Chief Medical Officer | 77,630 | $0 | 77,830 (Direct) | View |
Ownership | 2019-10-02 6:07 pm | N/A 2029-02-28 | Aprea Therapeutics Inc. | APRE | Attar Eyal C. SVP, Chief Medical Officer | 0 | $0 | 262,736 (Direct) | View |